Catalog No.
RVV19504
Species reactivity
Human papillomavirus 33 (HPV33)
Host species
Mouse
Isotype
IgG2b
Clonality
Monoclonal
Target
L1, Major capsid protein L1
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
P06416
Applications
ELISA-det, Neutralization
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
6G9
Worldwide genetic variations in high-risk human papillomaviruses capsid L1 gene and their impact on vaccine efficiency., PMID:33636291
Comprehensive Assessment of the Antigenic Impact of Human Papillomavirus Lineage Variation on Recognition by Neutralizing Monoclonal Antibodies Raised against Lineage A Major Capsid Proteins of Vaccine-Related Genotypes., PMID:32967963
Impact of naturally occurring variation in the human papillomavirus (HPV) 33 capsid proteins on recognition by vaccine-induced cross-neutralizing antibodies., PMID:28691664
Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles., PMID:27147749
Pre-clinical immunogenicity of human papillomavirus alpha-7 and alpha-9 major capsid proteins., PMID:25203446
Amino acid sequence diversity of the major human papillomavirus capsid protein: implications for current and next generation vaccines., PMID:23722024
Production of human papillomavirus type 33 L1 major capsid protein and virus-like particles from Bacillus subtilis to develop a prophylactic vaccine against cervical cancer., PMID:22305172
InterSCOPE study: Associations between esophageal squamous cell carcinoma and human papillomavirus serological markers., PMID:22228147
Production of L1 protein from different types of HPV in Pichia pastoris using an integrative vector., PMID:22030867
Production and purification of human papillomavirus type 33 L1 virus-like particles from Spodoptera frugiperda 9 cells using two-step column chromatography., PMID:20716445
Characterization of neutralizing epitopes within the major capsid protein of human papillomavirus type 33., PMID:17014700
Identification of two cross-neutralizing linear epitopes within the L1 major capsid protein of human papillomaviruses., PMID:12050360
In vitro infection and type-restricted antibody-mediated neutralization of authentic human papillomavirus type 16., PMID:9444988
Analysis of type-restricted and cross-reactive epitopes on virus-like particles of human papillomavirus type 33 and in infected tissues using monoclonal antibodies to the major capsid protein., PMID:7996132
Production and characterisation of a monoclonal antibody to human papillomavirus type 16 using recombinant vaccinia virus., PMID:2166093
For research use only. Not for human or drug use.
